Richard E Uihlein
Director, 10% owner at Galectin Therapeutics Inc (GALT)
Richard E Uihlein has filed 11 insider reports with the SEC since March 2021, as director and 10% owner at Galectin Therapeutics Inc (GALT). The latest filing, on August 4, 2026, reports exercise or conversion of a derivative at Galectin Therapeutics Inc (GALT).
- Filings
- 11
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Richard E Uihlein is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director, 10% owner | 10,332,676 | $2.69 | Aug 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 31, 2026GALTDirector Uihlein Richard E exercised 34,376,167 shares at a strike of $3.08Form 4Exercise or conversion of a derivative
- Jan 16, 2026GALTDirector Uihlein Richard E was granted 13,158 shares, increasing direct ownership by 0.13% to 10,332,676 unitsForm 4Grant or award
- Jan 23, 2025GALTDirector Uihlein Richard E was granted 32,520 shares, increasing direct ownership by 0.32% to 10,301,271 unitsForm 4Grant or award
- Jan 24, 2024GALTUihlein Richard E was granted 23,256 shares, increasing direct ownership by 0.23% to 10,268,751 unitsForm 4Grant or award
- Sep 26, 2023GALTUihlein Richard E exercised 2,236,204 shares at a strike of $4.49, increasing direct ownership by 28% to 10,235,495 unitsForm 4Exercise or conversion of a derivative
- Jan 26, 2023GALTSEC Form 4: Uihlein Richard E was granted 36,036 shares, increasing direct ownership by 0.45% to 7,999,291 unitsForm 4Grant or award
- Jan 24, 2022GALTSEC Form 4: Uihlein Richard E was granted 17,677 shares, increasing direct ownership by 0.22% to 7,936,677 unitsForm 4Grant or award
- Dec 20, 2021GALTSEC Form 4 filed by Uihlein Richard EForm 4Grant or award
- Sep 17, 2021GALTSEC Form 4 filed by Uihlein Richard EForm 4Grant or award
- Apr 16, 2021GALTSEC Form 4 filed by Uihlein Richard EForm 4Grant or award
- Mar 25, 2021GALTSEC Form 4 filed by E Richard UihleinForm 4Grant or award
Compare Richard E Uihlein with
- Richard E Uihlein vs Khurram Jamil1 shared
- Richard E Uihlein vs Harold H. Shlevin1 shared
- Richard E Uihlein vs Henry Brem1 shared
- Richard E Uihlein vs Kary Eldred1 shared
- Richard E Uihlein vs Joel Lewis1 shared
- Richard E Uihlein vs Benjamin Carson Sr1 shared
Other insiders at the same companies
- Khurram JamilGALT
- Harold H. ShlevinGALT
- Henry BremGALT
- Kary EldredGALT
- Joel LewisGALT
- Benjamin Carson SrGALT
- Richard A. Zordani Jr.GALT
- Kevin D FreemanGALT
- Jack W CallicuttGALT
- Gilbert S OmennGALT
- Gilbert F AmelioGALT
- Elissa J. SchwartzGALT
- 10X Fund, L.P.GALT
- James C CzirrGALT
- Marc RubinGALT
Questions about Richard E Uihlein
- What is Richard E Uihlein's role at Galectin Therapeutics Inc?
- Richard E Uihlein reports to the SEC as director and 10% owner at Galectin Therapeutics Inc (GALT), according to the latest filing on August 4, 2026.
- How many shares does Richard E Uihlein own?
- After the latest filing that states it, Richard E Uihlein directly owned 10,332,676 shares of Galectin Therapeutics Inc (GALT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Richard E Uihlein bought or sold stock recently?
- No open-market purchases or sales by Richard E Uihlein are on file. The filings report exercise or conversion of a derivative and grant or award.
- How do I get alerts when Richard E Uihlein files?
- Follow Richard E Uihlein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Richard E Uihlein (SEC CIK 0001694903). Totals count each trade once, skipping amendments whose original is on file, from Mar 29, 2021 on. View on SEC EDGAR · Get this as JSON